Parkinson's & Movement disorders
Scientists identify new target for Parkinson's therapies
A master control region of a protein linked to Parkinson's disease has been identified for the first time.
Mar 9, 2020
0
108
Page 3 - News tagged with alpha-synuclein protein
Neuroscience
Brain diseases with molecular diversity
Parkinson's and multisystem atrophy (MSA), both neurodegenerative diseases, are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German Center for Neurodegenerative Diseases (DZNE) ...
Dec 5, 2019
0
26
Neuroscience
Study highlights protein variability in neurodegenerative diseases
A new University of Toronto study sheds light on how protein strains vary in the brains of those affected by progressive neurodegenerative diseases like Parkinson's, suggesting the need for patient-specific medicines.
Dec 4, 2019
0
54
Parkinson's & Movement disorders
Discovery could lead to new treatments for Parkinson's, other brain diseases
A small protein previously associated with cell dysfunction and death in fact serves a critical function in repairing breaks in DNA, according to new research led by scientists at Oregon Health & Science University.
Jul 29, 2019
0
242
Parkinson's & Movement disorders
Protein-linked sugars are crucial for the uptake of proteins linked to Parkinson's disease
Parkinson's disease, a neurodegenerative disorder that affects more than 6 million people worldwide, is caused by the buildup of alpha-synuclein proteins in the brain. The biological function of alpha-synuclein is still not ...
Jul 3, 2019
1
2
Medical research
Breaking down pathological protein aggregates
ETH researchers have discovered a new mechanism that brain cells use to protect themselves from protein aggregates. Such aggregates play a key role in Parkinson's and other neurodegenerative diseases. This new finding might ...
Jun 6, 2019
0
47
Neuroscience
Researchers explore link between metal exposure and Parkinson's symptoms
A new study from Iowa State University biomedical researchers illuminates the biological processes by which exposure to some metals can contribute to the onset of Parkinson's-like symptoms.
Mar 13, 2019
2
176
Parkinson's & Movement disorders
Researchers find inhibiting one protein destroys toxic clumps seen in Parkinson's disease
A defining feature of Parkinson's disease is the clumps of alpha-synuclein protein that accumulate in the brain's motor control area, destroying dopamine-producing neurons. Natural processes can't clear these clusters, known ...
Nov 14, 2018
1
1267
Parkinson's & Movement disorders
Molecule capable of halting and reverting neurodegeneration caused by Parkinson's disease identified
The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibres responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease. The study, headed by ...
Sep 25, 2018
0
5563
Parkinson's & Movement disorders
Study identifies chaperone protein implicated in Parkinson's disease
Reduced levels of a chaperone protein might have implications for the development and progression of neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, according to new research from investigators ...
Aug 13, 2018
0
184
